Previous Close | 0.9380 |
Open | 0.9300 |
Bid | 0.8697 x 100 |
Ask | 0.9580 x 100 |
Day's Range | 0.9051 - 0.9300 |
52 Week Range | 0.7500 - 3.3400 |
Volume | |
Avg. Volume | 53,290 |
Market Cap | 31.576M |
Beta (5Y Monthly) | 0.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6500 |
Earnings Date | May 11, 2024 - May 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for INKT
MiNK Therapeutics, Inc. (INKT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2023 Earnings Call Transcript March 21, 2024 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.15. INKT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day everyone, and welcome […]
Q4 2023 Mink Therapeutics Inc Earnings Call